In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
A panel of experts will discuss what they have learnt from the last 2 years to take forward to future congress offerings, while also exploring what HCPs want when joining congresses both virtually or face-to-face.
MAPS speaks with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.
This virtual presentation focuses on 3 aspects of RWE: What are RWE and Real-World Data (RWD), and how are they different? What are relevant legal and regulatory considerations associated with using RWE for product label expansion? How have applicants successfully used RWE to obtain approval for new drug and medical device indications?
Medical Affairs teams are innovating their approach to engaging patients and empowering people to manage their chronic health conditions. Here, we explore one case study of people living with hidradenitis suppurativa.
This webinar seeks to help Medical Affairs professionals better understand the business of life science companies, how their efforts impact the overall capability to commercialize a product, and contemporary ways to bridge the commercialization interface between their department and Marketing & Sales.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
This webinar will discuss how MA colleagues are best positioned to explore the fusion of PE and PED in the post-launch phase, including generation and use of RWD and RW evidence, and will share guidance and information on several industry-supported resources, to enable MA colleagues to implement PE and evidence strategies in their function.
This Webinar aims to achieve awareness on challenges and solutions when listening to, and interacting with, Digital Opinion Leaders.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.